Aptis, a subsidiary of Dong-A ST, said on the 27th that it signed a business agreement with Cops Bio for joint research on a new antibody–degrader conjugate (DAC) drug. An antibody–drug conjugate (ADC ...

On November 26, Aptis and Kops Bio announced that they had signed a business agreement for joint research on next-generation Degrader-Antibody Conjugate (DAC) new drugs. The purpose of this agreement ...

Alstom and NTL presented today in Duppigheim (Alsace, France) Aptis, an innovative mobility solution. As cities are looking for smarter, more efficient and more connected means of transportation, ...

Idience, a cancer drug development company of Ildong Pharmaceutical Group, announced on the 12th that it has signed a joint development agreement with Aptis, a subsidiary of Dong-A Socio Group ...